FDA inspection

Summit Biosciences Inc.: FDA inspection ending Jun 18, 2015

FDA inspection 933643 · No Action Indicated (NAI) · Lexington, KY

Key facts

Inspection ID 933643
Firm Summit Biosciences Inc.
FEI number 3007577023
Address 1513 Bull Lea Rd
City Lexington
State KY
ZIP 40511
Country United States
Fiscal year 2015
Inspection end date Jun 18, 2015
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections